In vitro activities against mycobacteria of two longacting rifamycins, FCE22807 and CGP40/469A (SPAS-565)
- 1 June 1990
- Vol. 71 (2) , 109-115
- https://doi.org/10.1016/0041-3879(90)90005-s
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- New rifamycinsDrugs of the Future, 1988
- In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisTubercle, 1987
- In vitro activity of new rifamycins aganst rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaTubercle, 1987
- In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisTubercle, 1987
- ChemInform Abstract: New Long-Acting 3-Azinomethyl-Rifamycins.Chemischer Informationsdienst, 1986
- Laboratory evaluation of a new long-acting 3-azinomethylrifamycin FCE 22250.The Journal of Antibiotics, 1985
- Assay of rifampicin in serumJournal of Clinical Pathology, 1974